Udhayvir Grewal։ Bridging the Gap in Chemotherapy-Induced Thrombocytopenia
Udhayvir Grewal, GI Oncologist at Winship Cancer Institute of Emory University, shared a post on X about a recent article he and his colleagues co-authored, published in Journal of Clinical Oncology, adding:
” Hot off the press! Enjoyed writing this commissioned piece ‘Bridging the Gap’ in JCO ASCO on the role of thrombopoeitin receptor agonists for the management of chemotherapy induced thrombocytopenia in GI malignancies; with (a commentary on the recently published ACT-GI trial).
We propose a three dimensional framework to guide patient selection.”
Title: Bridging the Gap: Clinical Integration of Thrombopoietin Receptor Agonists in GI Cancer–Associated Chemotherapy-Induced Thrombocytopenia
Authors: Raafat S. Alameddine, Timothy J. Brown, Nicholas J. Hornstein, Udhayvir S. Grewal
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 8, 2026, 14:58Manuel Monreal: DOACs Show Advantages Over VKAs in DVT Patients
-
Sep 8, 2026, 14:43Kemal Karaagac: LAAC vs DOACs in Atrial Fibrillation
-
Sep 8, 2026, 14:43Talat Kılıç: Can Heparin Be Used Again After HIT?
-
Sep 8, 2026, 14:39Abdul Mannan: The Case Report That Changed How I Read Bleeding Disorders
-
Sep 8, 2026, 14:25Zain Khalpey: Why the Underlying Mechanism Matters in Myocardial Ischemia
-
Sep 8, 2026, 13:26Akhil Santhosh: Closing the Gap in Chemotherapy-Induced Thrombocytopenia
-
Sep 8, 2026, 13:12Roman Rodionov: Is Lp(a) Another Homocysteine?
-
Sep 8, 2026, 12:48Denis Oduor: Beyond the Donation Chair and Into a Legacy of Hope
-
Sep 8, 2026, 12:24Alejandro González Veliz: Can a Stent Cause a Heart Attack?